- Stocks
- Healthcare
- NASDAQ: DVAX

Price (delayed)

$7.80

Market cap

$893.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

$1.03B

DVAX's revenue has surged by 195% year-on-year and by 156% since the previous quarter

The company's gross profit has surged by 161% QoQ

DVAX's quick ratio is down by 38% YoY but it is up by 19% QoQ

What are the main financial stats of DVAX

Market
Valuations
Earnings

Shares outstanding

114.59M

Market cap

$893.79M

Enterprise value

$1.03B

Price to earnings (P/E)

N/A

Price to book (P/B)

8.86

Price to sales (P/S)

7.35

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

8.64

Revenue

$118.97M

EBIT

-$42.71M

EBITDA

-$35.77M

Free cash flow

-$23.97M

Per share
Balance sheet
Liquidity

EPS

-$0.62

Free cash flow per share

-$0.21

Book value per share

$0.88

Revenue per share

$1.06

TBVPS

$4.36

Total assets

$490.12M

Total liabilities

$390.36M

Debt

$213.68M

Equity

$99.76M

Working capital

$318.11M

Debt to equity

2.14

Current ratio

3.91

Quick ratio

2.9

Net debt/EBITDA

-3.76

Margins
Efficiency
Dividend

EBITDA margin

-30.1%

Gross margin

71.5%

Net margin

-51.9%

Operating margin

-17.3%

Return on assets

-16.2%

Return on equity

-86.4%

Return on invested capital

-9.2%

Return on capital employed

-11.2%

Return on sales

-35.9%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Dynavax Technologies stock price performed over time

Intraday

6.41%

1 week

-20.49%

1 month

-23.08%

1 year

85.71%

YTD

75.28%

QTD

-20.65%

How have Dynavax Technologies's revenue and profit performed over time

Revenue

$118.97M

Gross profit

$85.08M

Operating income

-$20.53M

Net income

-$61.75M

Gross margin

71.5%

Net margin

-51.9%

DVAX's revenue has surged by 195% year-on-year and by 156% since the previous quarter

The company's gross profit has surged by 161% QoQ

The company's operating margin has surged by 94% YoY and by 88% QoQ

Dynavax Technologies's net margin has soared by 83% YoY and by 68% from the previous quarter

What is Dynavax Technologies's growth rate over time

What is Dynavax Technologies stock price valuation

P/E

N/A

P/B

8.86

P/S

7.35

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

8.64

DVAX's EPS has soared by 64% YoY and by 17% from the previous quarter

Dynavax Technologies's equity has soared by 70% from the previous quarter

DVAX's P/B is 26% below its 5-year quarterly average of 11.2 and 18% below its last 4 quarters average of 10.1

DVAX's revenue has surged by 195% year-on-year and by 156% since the previous quarter

The P/S is 98% less than the 5-year quarterly average of 406.7 and 51% less than the last 4 quarters average of 14.1

How efficient is Dynavax Technologies business performance

The ROE has soared by 88% YoY and by 43% from the previous quarter

DVAX's ROS has soared by 86% YoY and by 70% from the previous quarter

Dynavax Technologies's ROA has soared by 65% YoY and by 30% from the previous quarter

Dynavax Technologies's return on invested capital has surged by 65% YoY and by 28% QoQ

What is DVAX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DVAX.

How did Dynavax Technologies financials performed over time

Dynavax Technologies's total assets is 26% higher than its total liabilities

Dynavax Technologies's total assets has surged by 89% YoY and by 39% QoQ

The company's total liabilities has surged by 58% YoY and by 33% QoQ

Dynavax Technologies's debt is 114% more than its equity

The debt to equity has plunged by 88% YoY and by 42% from the previous quarter

Dynavax Technologies's equity has soared by 70% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.